baclofen has been researched along with Chronic Kidney Diseases in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Cmax was not statistically different between the groups, while AUC and T1/2el increased, and CL/F decreased, with increasing severity of CKD." | 2.79 | Pharmacokinetic characterization of baclofen in patients with chronic kidney disease: dose adjustment recommendations. ( Barrière, O; Larouche, R; Perreault, MM; Pichette, V; Shink, E; Tanguay, M; Tremblay, PO; Vlavonou, R, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Grech, E | 1 |
| Attard, SC | 1 |
| Attard, A | 1 |
| Farrugia, E | 1 |
| Muanda, FT | 1 |
| Blake, PG | 1 |
| Weir, MA | 1 |
| Bathini, L | 1 |
| Chauvin, K | 1 |
| Dixon, SN | 1 |
| McArthur, E | 1 |
| Sontrop, JM | 1 |
| Moist, L | 1 |
| Kim, RB | 1 |
| Garg, AX | 1 |
| Mitsuboshi, S | 1 |
| Pelter, M | 1 |
| Bagsic, SRS | 1 |
| Nicholson, L | 1 |
| Sriperumbuduri, S | 1 |
| Hiremath, S | 1 |
| Vlavonou, R | 1 |
| Perreault, MM | 1 |
| Barrière, O | 1 |
| Shink, E | 1 |
| Tremblay, PO | 1 |
| Larouche, R | 1 |
| Pichette, V | 1 |
| Tanguay, M | 1 |
| Niehaus, MT | 1 |
| Elliott, NC | 1 |
| Katz, KD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pharmacokinetic and Bioequivalence Comparison of Baclofen and Chlorzoxazone When Administered Individually or Concurrently[NCT05257447] | Phase 1 | 19 participants (Actual) | Interventional | 2022-04-27 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for baclofen and Chronic Kidney Diseases
| Article | Year |
|---|---|
The case for cautious consumption: NSAIDs in chronic kidney disease.
Topics: Acute Kidney Injury; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Baclofen; Cost-Ben | 2019 |
1 trial available for baclofen and Chronic Kidney Diseases
| Article | Year |
|---|---|
Pharmacokinetic characterization of baclofen in patients with chronic kidney disease: dose adjustment recommendations.
Topics: Adult; Aged; Aged, 80 and over; Baclofen; Creatinine; Female; GABA-B Receptor Agonists; Glomerular F | 2014 |
5 other studies available for baclofen and Chronic Kidney Diseases
| Article | Year |
|---|---|
Baclofen toxicity in a patient with advanced chronic kidney disease.
Topics: Baclofen; Chronic Disease; Humans; Kidney Failure, Chronic; Renal Insufficiency, Chronic | 2023 |
Association of Baclofen With Falls and Fractures in Patients With CKD.
Topics: Accidental Falls; Aged; Baclofen; Fractures, Bone; GABA-B Receptor Agonists; Global Health; Humans; | 2021 |
Association Between Baclofen and Respiratory Depression in Patients With Chronic Kidney Disease.
Topics: Age Factors; Aged; Baclofen; Body Weight; Female; Humans; Male; Middle Aged; Propiophenones; Renal I | 2021 |
Oral baclofen toxicity in older patients with chronic kidney disease.
Topics: Administration, Oral; Aged; Baclofen; Contraindications, Drug; Female; Humans; Male; Muscle Relaxant | 2021 |
Baclofen Toxicity Causing Acute, Reversible Dyskinesia.
Topics: Aged, 80 and over; Back Pain; Baclofen; Coronary Artery Disease; Diabetes Mellitus; Drug Interaction | 2016 |